王征(未出国) 发表于 2012-6-27 16:26:35

BD&L Postdoctoral Fellow - Roche Partnering

<DIV>
<P style="TEXT-JUSTIFY: inter-ideograph; TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal><B><U><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH" lang=EN-US>Job Summary</SPAN></U></B><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH" lang=EN-US>&nbsp;</SPAN><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: #1f497d; FONT-SIZE: 12pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU></SPAN></P>
<P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>Work with BD&amp;L Heads and Finders, and internal stakeholders, to understand </SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU>the </SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>needs</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU> for China Research and Early Development (pRED China) and Commercial Affiliate (SRPL)</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>.&nbsp; Triage and refer or respond to unsolicited proposals.&nbsp; Conduct landscape analyses, attend scientific and partnering conferences and review the scientific literature to identify opportunities that are consistent with </SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU>the </SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>needs</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU> for</SPAN><SPAN style="mso-ansi-language: EN-AU" lang=EN-AU><FONT size=2 face=Arial> </FONT></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN" lang=EN-US>pRED China</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU> and SRPL</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>.</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU>&nbsp; </SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>Contribute scientific expertise and facilitate activities in Disease and Technology Areas.</SPAN></P>
<P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: #1f497d; FONT-SIZE: 12pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-GB" lang=EN-GB>&nbsp;</SPAN></P>
<P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal><B><U><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH" lang=EN-US>Essential Job Functions</SPAN></U></B></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 12.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>Work with BD&amp;L Heads and Finders, and </SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU>internal stakeholders</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>, to understand needs</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU> for pRED China and SRPL</SPAN><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: #1f497d; FONT-SIZE: 12pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU></SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>Search scientific and business development databases, and identify and summarize relevant scientific publications</SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>Attend scientific conferences to identify new opportunities that match our stakeholder’s criteria for innovative products and technologies </SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>Identify external partners working in the areas of interest to partnering teams and our internal stakeholders</SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>Monitor and attend public presentations and teleconferences of external companies of interest to Roche</SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>Develop biological target and pathway landscape analyses for areas of focus for Roche Pharma</SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>Screen external proposals, identify those of interest and respond to potential partners as appropriate, and</SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-fareast-font-family: Symbol; mso-bidi-font-size: 12.0pt; mso-bidi-font-family: Symbol" lang=EN-US><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>Input opportunities into our proprietary database for tracking and monitoring.</SPAN><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: #1f497d; FONT-SIZE: 12pt; mso-fareast-language: DE-CH" lang=EN-US></SPAN></P>
<P style="TEXT-JUSTIFY: inter-ideograph; TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal><B><U><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH" lang=EN-US>Education</SPAN></U></B><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: #1f497d; FONT-SIZE: 12pt; mso-fareast-language: DE-CH" lang=EN-US></SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo2; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>recent completion of a Science, Medical or Pharmacy degree is required, with a PhD, MD or PharmD degree preferred </SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo2; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>this role could suit an MBA graduate with a strong scientific background</SPAN></P>
<P style="TEXT-JUSTIFY: inter-ideograph; TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal><B><U><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH" lang=EN-US>Experience</SPAN></U></B><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: #1f497d; FONT-SIZE: 12pt; mso-fareast-language: DE-CH" lang=EN-US></SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo2; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 12.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>understanding of pharmaceuticals</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU>, </SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>drug development</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU> and commercialization</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU> is helpful </SPAN><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: #1f497d; FONT-SIZE: 12pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU></SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo2; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>knowledge of&nbsp;drug discovery technologies, oncology, immunology, virology, neurobiology, or cardiovascular/metabolic diseases is helpful </SPAN></P>
<P style="TEXT-JUSTIFY: inter-ideograph; TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH" lang=EN-US>&nbsp;<B><U>Additional Requirements</U></B></SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo2; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>fluency in English </SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU>and Chinese </SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>is required</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: ZH-CN; mso-ansi-language: EN-AU" lang=EN-AU>.</SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>&nbsp; </SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo2; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>ability to work independently with a strong drive, as well as the ability to work in interdisciplinary teams is required </SPAN></P>
<P style="TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo2; tab-stops: list 18.0pt" class=MsoNormal><SPAN style="FONT-FAMILY: Symbol; COLOR: #1f497d; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU; mso-fareast-font-family: Symbol; mso-bidi-font-size: 11.0pt; mso-bidi-font-family: Symbol" lang=EN-AU><SPAN style="mso-list: Ignore"><FONT size=2>·</FONT><SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: #1f497d; FONT-SIZE: 11pt; mso-fareast-language: DE-CH; mso-ansi-language: EN-AU" lang=EN-AU>outstanding interpersonal and communication skills are required </SPAN></P></DIV>

王征(未出国) 发表于 2012-6-27 16:27:41

邮件:jonathan.wang.jw2@roche.com
页: [1]
查看完整版本: BD&L Postdoctoral Fellow - Roche Partnering